In light of EFSA’s recent scientific evaluations, Cantox will be providing the most up-to-date status on Article 13 and 14 health claims in the EU.

Cantox is excited to announce that officials from EFSA, Health Canada, and the United States Food and Drug Administration will compare and contrast the standards of evidence required for health claim substantiation.

Don’t miss this opportunity to hear directly from the experts about the most common fatal flaws made in health claim submissions and how to ensure your biomarkers of disease risk and other health outcomes are valid.

For more information on this event click here.